| NCT ID | NCT07174388 |
| Status | Recruiting |
| Phase | — |
| Sponsor | N-Power Medicine |
| Condition | Non Small Cell Lung Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 550 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2029-04 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
A study to create control arms using current and future information in patients with lung cancer that has spread who have already received chemotherapy.
Eligibility Criteria
Inclusion Criteria: 1\. \> 18 years of age at the time of informed consent 2. Pathologically confirmed NSCLC 3 .ECOG Performance of \>1 and fit for further systemic therapy on a NCCN approved regimen (within 4 weeks prior or 14 days after starting second line therapy) 4. Life expectancy of more than 3 months 5. Able to understand and sign informed consent \*see protocol for cohort specific inclusion criteria\* Exclusion Criteria: 1. Unable to provide informed consent 2. Actively on a clinical trial of an investigational agent 3. Non protocol compliant baseline imaging scan (modality/coverage) prior to index date in patients included after the second or third line therapy has been initiated \*see protocol for cohort specific exclusion criteria\* -
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.